RELY just delivered its strongest quarterly print on record, yet insiders spent the past three weeks quietly lightening positions ahead of the release. That contrast — a blowout report met by steady insider selling — defines the week's most interesting tension.
The results, reported on May 6, were unambiguous. Q1 EPS came in at $0.23 against a $0.12 estimate — almost double the consensus. Revenue hit $452.8 million, beating estimates by roughly $14.8 million. Full-year 2026 revenue guidance was lifted to $1.96–$1.975 billion, above the prior $1.94–$1.96 billion range and slightly ahead of the $1.954 billion the Street had pencilled in. The stock was already up 48% over the prior month and 10% on the week going into the print; the earnings beat lands on top of a re-rating that's already been material.
The insider selling tells a more cautious story. Multiple officers and directors sold shares throughout April and into early May — well before the report. Director Phillip Riese sold 40,000 shares at $20.04 on April 17. Chief Legal Officer Saema Somalya executed three separate sell trades between April 15 and May 1, totalling roughly 66,000 shares. Director Joshua Hug sold in five tranches between April 14 and April 30, across a price range of $17.98 to $21.66. Net insider activity across the past 90 days reflects aggregate sales, with the pattern concentrated entirely on the sell side. None of these trades look distressed — prices climbed steadily through the period — but the breadth and frequency of selling into the rally is worth noting for investors assessing the conviction of the management team versus the market's enthusiasm.
Positioning in the broader market is relaxed. Short interest amounts to a modest 2.8% of free float, and the lending market is loose by any measure — borrow availability is wide, with cost to borrow running below 0.5% and drifting lower over the week. The short score, at 32.9, is unremarkable and drifting lower from an April peak near 34. Short sellers had been building into April (positions touched 6.8 million shares on April 20) but have since unwound roughly 15% of that, leaving the setup with no meaningful short squeeze overhang. Options positioning shows mild defensiveness — the put/call ratio at 0.55 is modestly above its 20-day average of 0.50, but the z-score of 1.6 barely qualifies as elevated. There is no crowded short, no tight borrow, and no extreme options skew — the market is not set up for a squeeze in either direction.
The Street remains constructive and has been moving targets higher. Keybanc lifted its target to $23 and Cantor Fitzgerald raised to $24 in late April, both ahead of the print. Goldman Sachs and JPMorgan have also been carrying positive ratings, though JPMorgan trimmed its target in January. With the stock now at $23.74, the mean analyst price target of $22.78 is already trading slightly through consensus — a common consequence when a stock re-rates faster than analysts update their models. EPS momentum is a standout: factor scores rank the company in the 83rd percentile on 30-day EPS momentum and the 92nd on 90-day momentum, with EPS surprise ranking at the 82nd percentile. The bull case — rapid revenue growth, share gains in remittance, improving EBITDA margins — is clearly the dominant narrative heading into Q2. The bear case focuses on competitive pressure and FX sensitivity, risks that feel more abstract against a quarter where EPS beat by 92%.
Closely correlated peer FLYW gained 7% on the week, broadly in line with Remitly's own move. GPN added 2.3%. EEFT, by contrast, lost 7% — divergence that suggests the week's payment sector move was stock-specific rather than purely thematic.
The next catalyst to watch is the Q2 guidance range ($483–$485 million in revenue against a $484.6 million consensus estimate) — a deliberately tight band that leaves almost no room for error if underlying transaction volume softens.
See the live data behind this article on ORTEX.
Open RELY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
